[go: up one dir, main page]

AR007970A1 - Pirroles sustituidos, su utilizacion y composiciones farmaceuticas que los comprenden - Google Patents

Pirroles sustituidos, su utilizacion y composiciones farmaceuticas que los comprenden

Info

Publication number
AR007970A1
AR007970A1 ARP970103310A ARP970103310A AR007970A1 AR 007970 A1 AR007970 A1 AR 007970A1 AR P970103310 A ARP970103310 A AR P970103310A AR P970103310 A ARP970103310 A AR P970103310A AR 007970 A1 AR007970 A1 AR 007970A1
Authority
AR
Argentina
Prior art keywords
substituted pyrroles
pharmaceutical compositions
formula
substituted
hydroxy
Prior art date
Application number
ARP970103310A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR007970A1 publication Critical patent/AR007970A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Se refiere a pirroles substituidos de la fórmula (I), en la que R es alquilo, alquiltio o hidroxi, donde el grupo alquilo puede estar sustituido ono por uno o varios sustituyentes, elegidos del conjunto formado por hidroxi, alcoxi, aminohal ógeno, ciano, tioalquilo, carboxi, derivados de ácidocarboxílico o alquilsulfinilo o R es un producto previo de síntesis de los pirroles sustituidos de fórmula (I) farmacéuticamente aceptables y a lassales farmacéuticamente aceptables delos com puestos de la fórmula (I) que son agentes antiproliferativos idóneos para el tratamiento del cáncer. Serefiere además a la utilización de dichos pirroles sustituidos y a composiciones farmacéuticas que los comprenden.
ARP970103310A 1996-07-29 1997-07-22 Pirroles sustituidos, su utilizacion y composiciones farmaceuticas que los comprenden AR007970A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2208096P 1996-07-29 1996-07-29

Publications (1)

Publication Number Publication Date
AR007970A1 true AR007970A1 (es) 1999-11-24

Family

ID=21807715

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103310A AR007970A1 (es) 1996-07-29 1997-07-22 Pirroles sustituidos, su utilizacion y composiciones farmaceuticas que los comprenden

Country Status (18)

Country Link
US (1) US5891901A (es)
EP (1) EP0915871B1 (es)
JP (1) JP2000516590A (es)
KR (1) KR20000029627A (es)
CN (1) CN1077572C (es)
AR (1) AR007970A1 (es)
AT (1) ATE347551T1 (es)
AU (1) AU739704B2 (es)
BR (1) BR9710902A (es)
CA (1) CA2262088A1 (es)
CO (1) CO4890846A1 (es)
DE (1) DE69737060D1 (es)
HR (1) HRP970417A2 (es)
MA (1) MA24288A1 (es)
PE (1) PE91498A1 (es)
TR (1) TR199900153T2 (es)
WO (1) WO1998004553A1 (es)
ZA (1) ZA976487B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1127500C (zh) * 1998-03-17 2003-11-12 弗·哈夫曼-拉罗切有限公司 抑制细胞增殖的取代双吲哚基马来酰亚胺
US6521658B1 (en) * 1999-05-28 2003-02-18 Abbott Laboratories Cell proliferation inhibitors
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
TWI335221B (en) * 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
US20050123975A1 (en) * 2003-11-19 2005-06-09 Applera Corporation Methods for determining the degradation state or concentration of nucleic acids
EP3169337A1 (en) 2014-07-17 2017-05-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
BR9710902A (pt) 1999-08-17
ZA976487B (en) 1998-01-29
EP0915871B1 (en) 2006-12-06
CN1226249A (zh) 1999-08-18
CN1077572C (zh) 2002-01-09
MA24288A1 (fr) 1998-04-01
AU739704B2 (en) 2001-10-18
KR20000029627A (ko) 2000-05-25
TR199900153T2 (xx) 1999-04-21
CO4890846A1 (es) 2000-02-28
HRP970417A2 (en) 1998-08-31
DE69737060D1 (de) 2007-01-18
JP2000516590A (ja) 2000-12-12
CA2262088A1 (en) 1998-02-05
US5891901A (en) 1999-04-06
WO1998004553A1 (en) 1998-02-05
PE91498A1 (es) 1998-12-22
EP0915871A1 (en) 1999-05-19
AU4296497A (en) 1998-02-20
ATE347551T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
RU94039542A (ru) Производные пиперазина как антагонисты 5-нт-рецепторов, способ получения, фармацевтическая композиция
BG66087B1 (bg) Хинолинонови производни като тирозин киназни инхибитори
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
CA2478374A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
DE60139639D1 (de) Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
ATE209034T1 (de) Taxolderivate
DE69709493D1 (de) Substituierte Indazolderivate
AR007970A1 (es) Pirroles sustituidos, su utilizacion y composiciones farmaceuticas que los comprenden
ES2167931T3 (es) Derivados bifenilicos sustituidos por un radical aromatico o heteroaromatico y composiciones farmaceuticas y cosmeticas que los contienen.
ATE192152T1 (de) Piperidinderivate mit paf antagonistischer wirkung
EE200000472A (et) Kasvajavastased toimeained
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
KR970010764A (ko) 크로몬 유도체, 그의 제조방법 및 의약 조성물
NO960632D0 (no) Nye bis-naftalimider for behandling av kreft
IT1256320B (it) Derivati eterociclici
EA200501233A1 (ru) 4-аминопиримидин-5-он
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2075074T3 (es) Acidos 3-fenil-5,6-dihidrobenzo(c)-acridin-7-carboxilicos y compuestos relacionados como agentes quimioterapeuticos para el cancer.
ATE237614T1 (de) Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
HUT63626A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
BR0112122A (pt) Composto de rutênio (ii) , uso de um composto, composição farmacêutica, método para tratar e/ou prevenir o câncer, e, processo para preparar um composto
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
DE60234024D1 (de) Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält

Legal Events

Date Code Title Description
FA Abandonment or withdrawal